Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer

Tumours with homologous recombination (HR) defects become sensitive to PARPi. Here, the authors show that androgen receptor (AR) regulates HR and AR inhibition activates the PARP pathway in vivo, thus inhibition of both AR and PARP is required for effective treatment of high risk prostate cancer.

Guardado en:
Detalles Bibliográficos
Autores principales: Mohammad Asim, Firas Tarish, Heather I. Zecchini, Kumar Sanjiv, Eleni Gelali, Charles E. Massie, Ajoeb Baridi, Anne Y. Warren, Wanfeng Zhao, Christoph Ogris, Leigh-Anne McDuffus, Patrice Mascalchi, Greg Shaw, Harveer Dev, Karan Wadhwa, Paul Wijnhoven, Josep V. Forment, Scott R. Lyons, Andy G. Lynch, Cormac O’Neill, Vincent R. Zecchini, Paul S. Rennie, Aria Baniahmad, Simon Tavaré, Ian G. Mills, Yaron Galanty, Nicola Crosetto, Niklas Schultz, David Neal, Thomas Helleday
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
Q
Acceso en línea:https://doaj.org/article/6dd1f31e993c4c649fd8af898835fe41
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6dd1f31e993c4c649fd8af898835fe41
record_format dspace
spelling oai:doaj.org-article:6dd1f31e993c4c649fd8af898835fe412021-12-02T15:38:57ZSynthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer10.1038/s41467-017-00393-y2041-1723https://doaj.org/article/6dd1f31e993c4c649fd8af898835fe412017-08-01T00:00:00Zhttps://doi.org/10.1038/s41467-017-00393-yhttps://doaj.org/toc/2041-1723Tumours with homologous recombination (HR) defects become sensitive to PARPi. Here, the authors show that androgen receptor (AR) regulates HR and AR inhibition activates the PARP pathway in vivo, thus inhibition of both AR and PARP is required for effective treatment of high risk prostate cancer.Mohammad AsimFiras TarishHeather I. ZecchiniKumar SanjivEleni GelaliCharles E. MassieAjoeb BaridiAnne Y. WarrenWanfeng ZhaoChristoph OgrisLeigh-Anne McDuffusPatrice MascalchiGreg ShawHarveer DevKaran WadhwaPaul WijnhovenJosep V. FormentScott R. LyonsAndy G. LynchCormac O’NeillVincent R. ZecchiniPaul S. RennieAria BaniahmadSimon TavaréIan G. MillsYaron GalantyNicola CrosettoNiklas SchultzDavid NealThomas HelledayNature PortfolioarticleScienceQENNature Communications, Vol 8, Iss 1, Pp 1-10 (2017)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Mohammad Asim
Firas Tarish
Heather I. Zecchini
Kumar Sanjiv
Eleni Gelali
Charles E. Massie
Ajoeb Baridi
Anne Y. Warren
Wanfeng Zhao
Christoph Ogris
Leigh-Anne McDuffus
Patrice Mascalchi
Greg Shaw
Harveer Dev
Karan Wadhwa
Paul Wijnhoven
Josep V. Forment
Scott R. Lyons
Andy G. Lynch
Cormac O’Neill
Vincent R. Zecchini
Paul S. Rennie
Aria Baniahmad
Simon Tavaré
Ian G. Mills
Yaron Galanty
Nicola Crosetto
Niklas Schultz
David Neal
Thomas Helleday
Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer
description Tumours with homologous recombination (HR) defects become sensitive to PARPi. Here, the authors show that androgen receptor (AR) regulates HR and AR inhibition activates the PARP pathway in vivo, thus inhibition of both AR and PARP is required for effective treatment of high risk prostate cancer.
format article
author Mohammad Asim
Firas Tarish
Heather I. Zecchini
Kumar Sanjiv
Eleni Gelali
Charles E. Massie
Ajoeb Baridi
Anne Y. Warren
Wanfeng Zhao
Christoph Ogris
Leigh-Anne McDuffus
Patrice Mascalchi
Greg Shaw
Harveer Dev
Karan Wadhwa
Paul Wijnhoven
Josep V. Forment
Scott R. Lyons
Andy G. Lynch
Cormac O’Neill
Vincent R. Zecchini
Paul S. Rennie
Aria Baniahmad
Simon Tavaré
Ian G. Mills
Yaron Galanty
Nicola Crosetto
Niklas Schultz
David Neal
Thomas Helleday
author_facet Mohammad Asim
Firas Tarish
Heather I. Zecchini
Kumar Sanjiv
Eleni Gelali
Charles E. Massie
Ajoeb Baridi
Anne Y. Warren
Wanfeng Zhao
Christoph Ogris
Leigh-Anne McDuffus
Patrice Mascalchi
Greg Shaw
Harveer Dev
Karan Wadhwa
Paul Wijnhoven
Josep V. Forment
Scott R. Lyons
Andy G. Lynch
Cormac O’Neill
Vincent R. Zecchini
Paul S. Rennie
Aria Baniahmad
Simon Tavaré
Ian G. Mills
Yaron Galanty
Nicola Crosetto
Niklas Schultz
David Neal
Thomas Helleday
author_sort Mohammad Asim
title Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer
title_short Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer
title_full Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer
title_fullStr Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer
title_full_unstemmed Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer
title_sort synthetic lethality between androgen receptor signalling and the parp pathway in prostate cancer
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/6dd1f31e993c4c649fd8af898835fe41
work_keys_str_mv AT mohammadasim syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer
AT firastarish syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer
AT heatherizecchini syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer
AT kumarsanjiv syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer
AT elenigelali syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer
AT charlesemassie syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer
AT ajoebbaridi syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer
AT anneywarren syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer
AT wanfengzhao syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer
AT christophogris syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer
AT leighannemcduffus syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer
AT patricemascalchi syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer
AT gregshaw syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer
AT harveerdev syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer
AT karanwadhwa syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer
AT paulwijnhoven syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer
AT josepvforment syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer
AT scottrlyons syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer
AT andyglynch syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer
AT cormaconeill syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer
AT vincentrzecchini syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer
AT paulsrennie syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer
AT ariabaniahmad syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer
AT simontavare syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer
AT iangmills syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer
AT yarongalanty syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer
AT nicolacrosetto syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer
AT niklasschultz syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer
AT davidneal syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer
AT thomashelleday syntheticlethalitybetweenandrogenreceptorsignallingandtheparppathwayinprostatecancer
_version_ 1718385993977954304